Abstract. A retrospective examination was made of archival data on the response of Plasmodium malariae infections in humans to chloroquine. The clearance time for P. malariae was longer than that for P. falciparum and P. vivax. Of 100 P. malariae–infected patients treated with 1,500 mg of chloroquine given over 3 days, 15 had detectable parasites for 7 days, 4 for 10 days, and 1 for 15 days after treatment. Of 17 patients treated intramuscularly with 450 mg of dihydrochloroquine, parasites persisted in 1 patient for 11 days. Of patients with chloroquine-sensitive P. falciparum, 44 cleared parasites by 6 days after treatment; 37 patients with P. vivax infections cleared parasites by day 5. The confirmation of chloroquine resistance may depen...
Abstract Background Plasmodium knowlesi is a cause of symptomatic and potentially fatal infections i...
Objective: To determine frequency of chlorolquine resistant plasmodium vivax and to observe clinical...
Abstract. Although chloroquine (CQ) resistance was first reported in Colombia in 1961 and sulfadoxin...
Background: Plasmodium falciparum strains that are resistant to standard-dose chloroquine can be tre...
Background: Plasmodium knowlesi is a cause of symptomatic and potentially fatal infections in humans...
Background: Plasmodium falciparum strains that are resistant to standard-dose chloroquine can be tre...
A total of 4,630 Malaria cases were admitted and treated at the Army General Hospital for a period f...
Increasing drug resistance in Plasmodium falciparum and a resurgence of malaria in tropical areas ha...
Extended chemoprophylaxis against endemic malaria raises concern with regard to susceptibility after...
Extended chemoprophylaxis against endemic malaria raises concern with regard to susceptibility after...
SummaryBackgroundChloroquine is the first-line treatment for Plasmodium vivax malaria in most endemi...
The therapeutic response to standard chloroquine therapy against Plasmodium vivax was evaluated in 3...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The therapeutic response to standard chloroquine therapy against Plasmodium vivax was evaluated in 3...
Abstract. Residents of malaria-endemic areas sometimes spontaneously clear Plasmodium falciparum inf...
Abstract Background Plasmodium knowlesi is a cause of symptomatic and potentially fatal infections i...
Objective: To determine frequency of chlorolquine resistant plasmodium vivax and to observe clinical...
Abstract. Although chloroquine (CQ) resistance was first reported in Colombia in 1961 and sulfadoxin...
Background: Plasmodium falciparum strains that are resistant to standard-dose chloroquine can be tre...
Background: Plasmodium knowlesi is a cause of symptomatic and potentially fatal infections in humans...
Background: Plasmodium falciparum strains that are resistant to standard-dose chloroquine can be tre...
A total of 4,630 Malaria cases were admitted and treated at the Army General Hospital for a period f...
Increasing drug resistance in Plasmodium falciparum and a resurgence of malaria in tropical areas ha...
Extended chemoprophylaxis against endemic malaria raises concern with regard to susceptibility after...
Extended chemoprophylaxis against endemic malaria raises concern with regard to susceptibility after...
SummaryBackgroundChloroquine is the first-line treatment for Plasmodium vivax malaria in most endemi...
The therapeutic response to standard chloroquine therapy against Plasmodium vivax was evaluated in 3...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
The therapeutic response to standard chloroquine therapy against Plasmodium vivax was evaluated in 3...
Abstract. Residents of malaria-endemic areas sometimes spontaneously clear Plasmodium falciparum inf...
Abstract Background Plasmodium knowlesi is a cause of symptomatic and potentially fatal infections i...
Objective: To determine frequency of chlorolquine resistant plasmodium vivax and to observe clinical...
Abstract. Although chloroquine (CQ) resistance was first reported in Colombia in 1961 and sulfadoxin...